Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05177289
NA

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

Sponsor: Jessa Hospital

View on ClinicalTrials.gov

Summary

This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.

Official title: Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-induced Alopecia: a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2022-02-28

Completion Date

2030-01

Last Updated

2023-09-29

Healthy Volunteers

No

Interventions

DEVICE

Theradome® LH80 pro

The Theradome LH80 pro is a wearable laser helmet device, which uses red laser light to stop hair loss, thicken existing hair and stimulate the growth of new hair.

DEVICE

Scalp cooling

Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.

Locations (1)

Jessa Hospital

Hasselt, Limburg, Belgium